This presentation contains forward-looking statements, which offer no guarantee with regard to future performance. These statements are made on the basis of management's views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Sonova's control. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sonova undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.
This presentation constitutes neither an offer to sell nor a solicitation to buy any securities. This presentation does not constitute an offering prospectus within the meaning of Article 652a of the Swiss Code of Obligations nor a listing prospectus within the meaning of the listing rules of SIX Swiss Exchange.
Sonova name, products names and logos are registered trademarks of Sonova.
Sennheiser™ is a registered trademark of Sennheiser electronic GmbH & Co. KG used under license by Sonova.
2
Sound result considering market challenges
Solid sales growth across all businesses despite slower growth in specific higher price markets
Profitability development reflecting market headwinds, FX and expected dilution from first time consolidation of recent acquisitions
Continued focus on innovation with successful launch of Phonak Lumity platform, delivering improved hearing performance
Broadening consumer access and market reach through further AC network expansion and entry into the consumer hearing market
Guidance remains in place - expecting to reach the lower end of the FY 2022/23 range
3
Sonova Group
4
Sonova Group results
Key highlights - HY 2022/23
Sales
EPS (adj.)
Sales outlook
CHF 1,847 m
CHF 4.90 per share
+15-19%
+17.9% in LC
+7.0% in LC
growth in LC
+15.1% in CHF
+0.8% in CHF
in FY 2022/23
EBITA (adj.)
Innovation
EBITA (adj.) outlook
CHF 398.1 m
Phonak Lumity
+ 6-10%
+3.0% in LC
Successful launch
growth in LC
-2.0% in CHF
and positive market
in FY 2022/23
response
Note: adj. refers to adjusted figures; for details, please refer to Appendix - Non-GAAP adjustments.
5
Um den Rest dieser Noodl zu lesen, rufen Sie bitte die Originalversion auf, und zwar hier.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Sonova Holding AG published this content on 14 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 November 2022 06:11:24 UTC.
Sonova Holding AG is the world's leading provider of innovative hearing solutions. Its broad product portfolio includes traditional hearing aids, cochlear implants and wireless communication systems. Net sales break down by family of products as follows:
- hearing aids (92.3%);
- cochlear implants (7.7%).
The geographical breakdown of sales is as follows: Switzerland (1.2%%), Europe/Middle East/Africa (48.8%), the United States (30.8%), the Americas (7.3%) and Asia/Pacific (11.9%).
SONOVA HOLDING AG 
